Day: November 13, 2020

‘Unprecedented’ pace of COVID-19 drug development pushing Madison companies to expand

One such company, California-based Humanigen, developed its COVID-19 therapy, lenzilumab, using Catalent products and further contracted with Catalent for development, manufacturing and commercialization services. Though still in clinical trials, Humanigen has reported positive results for patients who used lenzilumab, based on early data.

Terraced house ‘shut down’ by court following repeated Covid-19 breaches

A terraced house has been closed following reports of repeated breaches of coronavirus restrictions. Manchester and Salford Magistrates’ Court issued a three-month closure order on the property on Carlton Street in Farnworth, Bolton, following complaints from residents about breaches of Covid-19 regulations and anti-social behaviour […]